Association Between Triglyceride Glucose Index with Cognitive Impairment and Dementia in Adult Population: A Meta-Analysis

Abstract

The current understanding of the correlation between insulin resistance (IR) and cognitive dysfunction is limited. Therefore, the objective of this systematic review and meta-analysis was to assess the association between the triglyceride glucose (TyG) index, a recently suggested indicator of IR, and cognitive impairment and dementia in the adult population. Observational studies pertinent to our research were identified through comprehensive searches of the PubMed, Embase, and Web of Science databases. To account for potential heterogeneity, the random-effects models were employed to aggregate the findings. This meta-analysis included ten observational studies involving 5602409 participants. Compared to those with the low TyG index, subjects with the high TyG index were significantly associated with the risk of cognitive impairment [risk ratio (RR): 1.39, 95% confidence interval (CI): 1.22 to 1.59, p<0.001; I2=45%) and dementia (RR: 1.30, 95% CI: 1.06 to 1.60, p=0.01; I2=50%). The association was consistent for Alzheimer’s disease (RR: 1.35, 95% CI: 1.04 to 1.76, p=0.03; I2=54%) and vascular dementia (RR: 1.18, 95% CI: 1.13 to 1.24, p<0.001; I2=0%). Subgroup analyses showed that the association between TyG index with cognitive impairment and dementia were stronger in cross-sectional studies than that in cohort studies (p for subgroup difference=0.02), but not significantly modified by age, sex, or diabetic status of the participants. In conclusion, a high TyG index may be associated with higher risk of cognitive impartment and dementia in adult population.

Keywords

triglyceride glucose index - cognitive impairment - dementia - meta-analysis - insulin

Publication History

Received: 19 December 2023

Accepted after revision: 07 March 2024

Article published online:
09 April 2024

• References

• 1 Andersson MJ, Stone J. Best medicine for dementia: the life-long defense of the brain. J Alzheimers Dis 2023; 94: 51-66
• 2 Livingston G, Huntley J, Sommerlad A. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020; 396: 413-446
• 3 [Anonymous] Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022 7. e105-e125
• 4 Perez Palmer N, Trejo Ortega B, Joshi P. Cognitive impairment in older adults: epidemiology, diagnosis, and treatment. Psychiatr Clin North Am 2022; 45: 639-661
• 5 Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA 2014; 312: 2551-2561
• 6 Lin S, Chen M. Gender-specific impact of cognitive impairment on all-cause mortality in older persons: a meta-analysis. Exp Gerontol 2022; 165: 111860
• 7 Tisher A, Salardini A. A comprehensive update on treatment of dementia. Semin Neurol 2019; 39: 167-178
• 8 Sun MK. Potential therapeutics for vascular cognitive impairment and dementia. Curr Neuropharmacol 2018; 16: 1036-1044
• 9 Chen M, Zhang M, Wang S. et al. Association between insulin resistance and cognitive impairment. J Coll Physicians Surg Pak 2022; 32: 202-207
• 10 Cui Y, Tang TY, Lu CQ. et al. Insulin resistance and cognitive impairment: evidence from neuroimaging. J Magn Reson Imaging 2022; 56: 1621-1649
• 11 Kellar D, Craft S. Brain insulin resistance in Alzheimer’s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol 2020; 19: 758-766
• 12 Singh DD, Shati AA, Alfaifi MY. et al. Development of dementia in type 2 diabetes patients: mechanisms of insulin resistance and antidiabetic drug development. Cells 2022; 11: 3767
• 13 Khan SH, Sobia F, Niazi NK. et al. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr 2018; 10: 74
• 14 Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M. et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3347-3351
• 15 Mohd Nor NS, Lee S, Bacha F. et al. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes 2016; 17: 458-465
• 16 Anoop S, Jebasingh FK, Rebekah G. et al. The triglyceride/glucose ratio is a reliable index of fasting insulin resistance: observations from hyperinsulinaemic-euglycaemic clamp studies in young, normoglycaemic males from southern India. Diabetes Metab Syndr 2020; 14: 1719-1723
• 17 Tao LC, Xu JN, Wang TT. et al Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol 2022; 21 68 68
• 18 Faqih NT, Ashoor AF, Alshaikh SA. et al. Association of Alzheimer’s disease and insulin resistance in King Abdulaziz Medical City, Jeddah. Cureus 2021; 13: e19811
• 19 Hong S, Han K, Park CY. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimers Res Ther 2021; 13: 9
• 20 Li Y, Wang X, Cui J. et al. Increasing obstructive sleep apnea risk is associated with hearing impairment in middle-aged Chinese men – a cross-sectional study. PLoS One 2022; 17: e0268412
• 21 Teng Z, Feng J, Dong Y. et al. Triglyceride glucose index is associated with cerebral small vessel disease burden and cognitive impairment in elderly patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne) 2022; 13: 970122
• 22 Tong XW, Zhang YT, Yu ZW. et al. Triglyceride glucose index is related with the risk of mild cognitive impairment in type 2 diabetes. Diabetes Metab Syndr Obes 2022; 15: 3577-3587
• 23 Wang K, Xu L, Liu L. et al. Sex differences in the association between the change in triglyceride‑glucose index and cognitive decline: a population-based cohort study. J Affect Disord 2022; 316: 42-49
• 24 Weyman Y, Simental-Mendia LE, Camacho-Luis A. et al. The triglycerides and glucose index is associated with mild cognitive impairment in older adults. Endocr Res 2022; 47: 89-93
• 25 Ma Y, Wei S, Dang L. et al. Association between the triglyceride-glucose index and cognitive impairment in China: a community population-based cross-sectional study. Nutr Neurosci 2024; 27: 342-352
• 26 Sun J, Xie Z, Wu Y. et al. Association of the triglyceride-glucose index with risk of alzheimer’s disease: a prospective cohort study. Am J Prev Med 2023; 65: 1042-1049
• 27 Tian N, Fa W, Dong Y. et al. Triglyceride-glucose index, Alzheimer’s disease plasma biomarkers, and dementia in older adults: the MIND-China study. Alzheimers Dement (Amst) 2023; 15: e12426
• 28 Higgins J, Thomas J, Chandler J. et al. Cochrane handbook for systematic reviews of interventions version 6.2. The Cochrane Collaboration. 2021 www.training.cochrane.org/handbook
• 29 Wells GA, Shea B, O'Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010 http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
• 30 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
• 31 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
• 32 Muniyappa R, Lee S, Chen H. et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294: E15-E26
• 33 Tahapary DL, Pratisthita LB, Fitri NA. et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and triglyceride/glucose index. Diabetes Metab Syndr 2022; 16: 102581
• 34 Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6: 299-304
• 35 Vasques AC, Novaes FS, de Oliveira Mda S. et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011; 93: e98-e100
• 36 Stranahan AM, Norman ED, Lee K. et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 2008; 18: 1085-1088
• 37 Kenawy S, Hegazy R, Hassan A. et al. Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: protective role of metformin and saxagliptin. PLoS One 2017; 12: e0183565
• 38 Johnson LA, Torres ER, Impey S. et al. Apolipoprotein E4 and insulin resistance interact to impair cognition and alter the epigenome and metabolome. Sci Rep 2017; 7: 43701
• 39 Malin SK, Stewart NR, Ude AA. et al. Brain insulin resistance and cognitive function: influence of exercise. J Appl Physiol 1985; 2022: 1368-1380
• 40 Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009; 5: 673-681
• 41 De Paoli M, Zakharia A, Werstuck GH. The role of estrogen in insulin resistance: a review of clinical and preclinical data. Am J Pathol 2021; 191: 1490-1498
• 42 Yeap BB, Flicker L. Testosterone, cognitive decline and dementia in ageing men. Rev Endocr Metab Disord 2022; 23: 1243-1257
• 43 Russell JK, Jones CK, Newhouse PA. The role of estrogen in brain and cognitive aging. Neurotherapeutics 2019; 16: 649-665